First immunotherapy approved for cervical cancer in England and Scotland

Posted in Medicine on 21st May, 2023
by Alex Muller

The immunotherapy drug pembrolizumab (Keytruda) is now available for people in England and Scotland with some forms of advanced cervical cancer.

Drug combination elicits efficacious anti-tumor immunity against immunotherapy-resistant cancers

Posted in Medicine, Science on 19th Mar, 2023
by Alex Muller

Some patients still either don't respond to immunotherapy, or if they do, the effects are temporary, which highlights how crucial it is that we better understand the mechanisms leading to cancers resisting this kind of treatment.

Promising New Cancer Immunotherapy Developed

Posted in Medicine, Science on 21st Nov, 2022
by Alex Muller

“We believe the novel immunotherapy we’ve developed has great potential to move into clinical trials involving various types of cancer.”

New Discovery Could Lead to Improved Cancer Treatment

Posted in Medicine, Science on 25th Jul, 2022
by Alex Muller

The finding could improve cancer immunotherapy, a promising therapy that targets cancer cells using the body’s own immune system rather than radiation.

Interview with an Expert: Immunotherapy Update

Posted in Interviews, Medicine on 3rd Jul, 2022
by Alex Muller

Elizabeth M. Jaffee, M.D., is an internationally recognized expert in pancreatic cancer and immunotherapy research.